Serum Separation Gel Market (Type - Serum Separation Gel Integrated with Tube, and Serum Separation Gel Without Tube; End-user - Hospitals, Blood Bank, Biotechnology Companies, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

A recent report published by Infinium Global Research on serum separation gel market provides in-depth analysis of segments and sub-segments in the global as well as regional serum separation gel market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional serum separation gel market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global serum separation gel market.

Market Insight:

The global serum separation gel market was valued at USD 6.6 billion in 2022 and is expected to reach USD 10.10 billion in 2030, with a CAGR of 5.5% during the forecast period 2023-2030.

Serum separation gel is made of clear polypropylene, supplied capped, and labeled with an inert polyethylene cap. Serum separating gel is a substance that is been used in Serum Separation Tubes (SSTs), which is being widely utilized to collect blood samples in clinical assays. It contains spray-coated silica and polymer gel for serum separation. Serum separation gel enables the stable and reliable separation of the blood clot and serum with low influence on the clinical results. It provides high resistance to objects being exposed to radiation and offers effective recovery of Therapeutic Drug Monitoring (TDM). Furthermore, it provides faster and complete separation of blood cells, improving the serum stability offering a high level of plasma levels, and minimizing contamination. The coronavirus disease affected millions of people worldwide and caused disturbances at the global level. The demand for blood banks increased worldwide due to this infectious disease. However, the experience and measures implemented by countries to overcome the reduced activities and gain the confidence of donors in safe blood donation generated results.

The upsurge in the prevalence of chronic diseases is anticipated to increase the serum separation gels market share. The chronic diseases such as diabetes, heart disease, and cancer are becoming increasingly common, and these diseases require regular blood tests. This factors growing more demand for serum separation gels, as they are important for obtaining accurate blood test results. Additionally, Rise in the use of serum separation gel tubes for clinical research purposes in pathological science in order to control the growing worldwide burden of infectious disease. The rise in the number of contract research organizations and investments in the biotechnology industry is expected to boost the serum separation gels market share. However, the high cost of serum separation gel is higher which can affect its market growth. The price of serum separation gels can be a major restraint for some healthcare providers, particularly in developing countries. Moreover, serum separation gels production requires sterile conditions and with the rising number of manufacturing units in most of the emerging countries globally, it is expected to grow the serum separation gels market, creating opportunities in the serum separation gels market.

North America holds the largest market share in the serum separation gel market which is projected in the upcoming forecast period. An increasing percentage of the population with haematological disorders and various transferrable diseases, the rising investments in research & development of technology, and the advantage of gel tubes in testing for thyroid function propel growth for the serum separation gels market in this region. Additionally, the increased availability of favorable co-pay systems, as well as an increase in the number of blood banks with advanced infrastructure, drives market expansion. Moreover, the Asia Pacific is the fastest-growing region in the global serum separation gel market along with the rising rate of blood cell preservation in animals and an increasing number of biotechnology companies. In addition, well-known global brands such as Sekisui Diagnostics are expected to propel this market during the forecast period.

Report Scope of the Serum Separation Gel Market:

Segment Covered

The report on global serum separation gel market covers segments such as type, and end-user. On the basis of type, the sub-markets include serum separation gel integrated with tube, and serum separation gel without tube. On the basis of end-user, the sub-markets include hospitals, blood bank, biotechnology companies, and others.

Companies Profiled:

The report provides profiles of the companies in the market such as Cardinal Health, Becton Dickinson & Company, Greiner Bio-One International Gmbh, Sekisui Diagnostics, Hunan Liuyang Medical Instrument Factory, Bio-Rad Laboratories, Inc., Danaher, Deltalab., IntervacTechnology, and Biosigma S.p.A..

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the serum separation gel market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.